ADC Therapeutics SA (ADCT) Balance Sheet
As of 2026-06-30 (10-Q), ADC Therapeutics SA (ADCT) reported total assets of $279.4M, total liabilities of $507.6M and shareholders' equity of -$228.2M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $219.1M. Long-term debt: $116.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ADCTADC Therapeutics SAFollow ADCT — free
—
Price chart with a free account
- Market cap
- 183.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 466.5 | 326.4 | 278.6 | 250.9 | 261.3 | 219.1 | |
| Receivables | — | — | — | 73.0 | 25.2 | 20.3 | 29.1 | 28.0 | |
| Inventory | — | — | — | 12.1 | 16.2 | 2.3 | 4.2 | 4.9 | |
| Current assets | 122.6 | 450.5 | 525.2 | 435.0 | 336.3 | 291.3 | 306.3 | 261.7 | |
| Total assets | 137.7 | 513.7 | 618.0 | 490.9 | 354.8 | 322.0 | 323.2 | 279.4 | |
| Current liabilities | 19.9 | 40.4 | 73.9 | 81.9 | 67.7 | 80.5 | 70.2 | 86.3 | |
| Long-term debt | 0.0 | 34.8 | 87.2 | — | — | 113.6 | 115.5 | 116.6 | |
| Short-term debt | — | — | — | 12.5 | — | 0.0 | 3.0 | 6.2 | |
| Total liabilities | 26.5 | 178.2 | 451.9 | 411.4 | 503.0 | 524.6 | 509.0 | 507.6 | |
| Shareholders' equity | 111.2 | 335.5 | 154.0 | 79.5 | -148.2 | -202.6 | -185.8 | -228.2 |
USD millions · SEC XBRL
ADC Therapeutics SA — questions
- How much cash does ADC Therapeutics SA have?
- $219.1M in cash and cash equivalents as of 2026-06-30.
- How much debt does ADC Therapeutics SA have?
- $116.6M of long-term debt and $6.2M due within a year as of 2026-06-30.
- What are ADC Therapeutics SA's total assets?
- $279.4M as of 2026-06-30.
- What is ADC Therapeutics SA's shareholders' equity?
- -$228.2M as of 2026-06-30.
Every figure on this page comes from ADC Therapeutics SA's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.